CN1073603A - 用于治疗急性胰腺炎的缓激肽拮抗物 - Google Patents

用于治疗急性胰腺炎的缓激肽拮抗物 Download PDF

Info

Publication number
CN1073603A
CN1073603A CN92114564A CN92114564A CN1073603A CN 1073603 A CN1073603 A CN 1073603A CN 92114564 A CN92114564 A CN 92114564A CN 92114564 A CN92114564 A CN 92114564A CN 1073603 A CN1073603 A CN 1073603A
Authority
CN
China
Prior art keywords
arg
pro
gly
hyp
tic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN92114564A
Other languages
English (en)
Chinese (zh)
Inventor
T·格里斯贝彻
F·伦贝克
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of CN1073603A publication Critical patent/CN1073603A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/043—Kallidins; Bradykinins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/18—Kallidins; Bradykinins; Related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
CN92114564A 1991-12-21 1992-12-21 用于治疗急性胰腺炎的缓激肽拮抗物 Pending CN1073603A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP91122055 1991-12-21
EP91122055.6 1991-12-21

Publications (1)

Publication Number Publication Date
CN1073603A true CN1073603A (zh) 1993-06-30

Family

ID=8207466

Family Applications (1)

Application Number Title Priority Date Filing Date
CN92114564A Pending CN1073603A (zh) 1991-12-21 1992-12-21 用于治疗急性胰腺炎的缓激肽拮抗物

Country Status (27)

Country Link
US (1) US5670619A (OSRAM)
EP (1) EP0548825B1 (OSRAM)
JP (1) JP3588472B2 (OSRAM)
KR (1) KR930012034A (OSRAM)
CN (1) CN1073603A (OSRAM)
AT (1) ATE152733T1 (OSRAM)
AU (1) AU662188B2 (OSRAM)
BG (1) BG97168A (OSRAM)
BR (1) BR9205062A (OSRAM)
CA (1) CA2085781C (OSRAM)
CY (1) CY2116B1 (OSRAM)
CZ (1) CZ375692A3 (OSRAM)
DE (1) DE69219574T2 (OSRAM)
DK (1) DK0548825T3 (OSRAM)
ES (1) ES2101017T3 (OSRAM)
FI (1) FI925782L (OSRAM)
GR (1) GR3024179T3 (OSRAM)
HU (1) HU214056B (OSRAM)
IL (1) IL104163A0 (OSRAM)
MA (1) MA22743A1 (OSRAM)
MX (1) MX9207440A (OSRAM)
NO (1) NO924925L (OSRAM)
PL (1) PL297044A1 (OSRAM)
SI (1) SI9200406A (OSRAM)
TW (1) TW199863B (OSRAM)
YU (1) YU108192A (OSRAM)
ZA (1) ZA929829B (OSRAM)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7105172B1 (en) 1999-11-18 2006-09-12 Bolla John D Treatment of rosacea
US20040248809A1 (en) * 2003-02-07 2004-12-09 Aventis Pharma Deutschland Gmbh Use of antagonists of the bradykinin B2 receptor for the treatment of osteoarthrosis
RU2400263C1 (ru) * 2009-04-28 2010-09-27 Евгений Петрович Измайлов Способ консервативного и физиотерапевтического лечения острого панкреатита
RU2425669C1 (ru) * 2010-04-13 2011-08-10 Общество С Ограниченной Ответственностью "Гамаветфарм" Средство для профилактики и лечения острого и хронического панкреатита

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55500520A (OSRAM) * 1978-07-18 1980-08-14
US4693993A (en) * 1985-06-13 1987-09-15 Stewart John M Bradykinin antagonist peptides
US4801613A (en) * 1985-06-13 1989-01-31 Nova Technology Limited Partnership Bradykinin antagonist peptides
US4923963A (en) * 1987-09-02 1990-05-08 Nova Technology Limited Partnership Bradykinin antagonist peptides
US5162497A (en) * 1987-09-24 1992-11-10 The Administrators Of The Tulane Educational Fund Bradykinin analogs with non-peptide bond
IE63490B1 (en) * 1988-11-24 1995-05-03 Hoechst Ag Peptides having bradykinin antagonist action
DE4013270A1 (de) * 1990-04-26 1991-10-31 Hoechst Ag Peptide mit bradykinin-antagonistischer wirkung
DE3926822A1 (de) * 1989-08-14 1991-02-21 Hoechst Ag Peptide mit bradykinin-antagonistischer wirkung
WO1991009055A1 (en) * 1989-12-08 1991-06-27 Boston University Acylated bradykinin antagonists and uses therefor
EP0451791A2 (de) * 1990-04-12 1991-10-16 Hoechst Aktiengesellschaft Langwirksame Liposomenpräparate von Peptidarzneistoffen und Verfahren zu ihrer Herstellung

Also Published As

Publication number Publication date
MA22743A1 (fr) 1993-07-01
BR9205062A (pt) 1993-09-28
US5670619A (en) 1997-09-23
NO924925D0 (no) 1992-12-18
HU9204074D0 (en) 1993-04-28
YU108192A (sh) 1995-12-04
CA2085781A1 (en) 1993-06-22
ES2101017T3 (es) 1997-07-01
NO924925L (no) 1993-06-22
BG97168A (bg) 1993-12-24
FI925782A7 (fi) 1993-06-22
PL297044A1 (en) 1993-09-06
DE69219574T2 (de) 1997-11-13
JPH05255107A (ja) 1993-10-05
ATE152733T1 (de) 1997-05-15
CZ375692A3 (en) 1993-12-15
HU214056B (en) 1997-12-29
FI925782L (fi) 1993-06-22
DK0548825T3 (da) 1997-11-03
EP0548825B1 (en) 1997-05-07
TW199863B (OSRAM) 1993-02-11
CA2085781C (en) 2003-09-23
ZA929829B (en) 1994-02-16
DE69219574D1 (de) 1997-06-12
FI925782A0 (fi) 1992-12-18
MX9207440A (es) 1993-07-01
SI9200406A (en) 1993-06-30
JP3588472B2 (ja) 2004-11-10
EP0548825A1 (en) 1993-06-30
GR3024179T3 (en) 1997-10-31
HUT63336A (en) 1993-08-30
IL104163A0 (en) 1993-05-13
CY2116B1 (en) 2002-04-26
AU662188B2 (en) 1995-08-24
AU3021292A (en) 1993-06-24
KR930012034A (ko) 1993-07-20

Similar Documents

Publication Publication Date Title
CN1241942C (zh) 使用胰岛素的肽类似物治疗糖尿病的方法
CN1172434A (zh) 血管紧张肽ⅱ片段及其类似物在组织修复中的应用
CN1191272C (zh) 亲脂组分和血管活性肠肽片段的缀合物
CN1784240A (zh) 阿尔茨海默氏病的治疗方法
CN1238781A (zh) 七肽催产素类似物
CN1622941A (zh) 基于谷氨酰胺酰基的dpiv抑制剂
CN1124927A (zh) Yy肽类似物及其应用
CN1156965A (zh) 细胞因子调节剂及其在与改变的细胞因子水平相关的病理和状态中的应用方法
CN1521189A (zh) 甲状旁腺素类似物
CN1446201A (zh) 用作丙型肝炎病毒ns3－丝氨酸蛋白酶抑制剂的新型肽
CN1138335A (zh) 具有生长激素释放特性的化合物
CN1471538A (zh) 用于竞争性调节二肽基肽酶iv催化的肽结构
CN1133047A (zh) 治疗用肽衍生物
CN1684683A (zh) Hcv丝氨酸蛋白酶的有效抑制剂
CN1483831A (zh) 获得具有正确键合的胱氨酸键的胰岛素或胰岛素衍生物的方法
CN1487952A (zh) 具有血管活性肠肽的生物学活性的用于治疗肺动脉和小动脉高压的化合物
CN1582295A (zh) 新型表皮生长因子蛋白和基因及其使用方法
CN1072723A (zh) 三精氨酸胰岛素
CN1422278A (zh) kahalalide F及相关化合物
CN1458935A (zh) 含有整联蛋白结合基序的肽和治疗骨骼疾病的方法
CN1313149C (zh) 具有血管活性肠肽的生物学活性的化合物在治疗结节病中的用途
CN1871020A (zh) Gh－rh的拮抗类似物(2003)
CN1917898A (zh) 用于治疗非典型肺部感染的血管活性肠肽的生物活性物质
CN1073603A (zh) 用于治疗急性胰腺炎的缓激肽拮抗物
CN1057118C (zh) 重组的c140受体

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication